CIK 0001756262 · Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- Phone
- 9785520900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-01 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −7,388 | $120.01 | $887K | 0 |
| 2024-05-01 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −45,326 | 16,042 | ||
| 2024-05-01 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,458 | 14,584 | ||
| 2024-05-01 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,083 | 23,834 | ||
| 2024-04-17 | Hassanein Waleed H President & CEO | Option exercise 10b5-1 | +4,000 | $13.28 | $53K | 78,087 |
| 2024-04-17 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −4,000 | $95.12 | $380K | 74,087 |
| 2024-04-17 | Hassanein Waleed H President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 234,000 | ||
| 2024-04-10 | Hassanein Waleed H President & CEO | Option exercise 10b5-1 | +12,000 | $13.28 | $159K | 86,087 |
| 2024-04-10 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −12,000 | $95.09 | $1.1M | 74,087 |
| 2024-04-10 | Hassanein Waleed H President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,000 | 238,000 | ||
| 2024-04-09 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +8,341 | $16.14 | $135K | 33,526 |
| 2024-04-09 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +7,171 | $38.46 | $276K | 40,697 |
| 2024-04-09 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −10,532 | $90.14 | $949K | 30,165 |
| 2024-04-09 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −4,980 | $91.11 | $454K | 25,185 |
| 2024-04-09 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,341 | 0 | ||
| 2024-04-09 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,171 | 61,368 | ||
| 2024-04-08 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +4,388 | $16.14 | $71K | 29,573 |
| 2024-04-08 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −4,388 | $90.00 | $395K | 25,185 |
| 2024-04-08 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,388 | 8,341 | ||
| 2024-04-04 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +2,030 | $13.28 | $27K | 27,215 |
Page 18 of 20 · 390 trades